{"transactions":[{"id":697059,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-05T01:00:17.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 13, 2025, the Board of Directors of the Issuer granted stock options to Mr. Gustafson to purchase 60,000 shares of Common Stock.  Fifty percent (50%) of these options vested and became exercisable on the date that receipt of approval of the option grants by the Issuer's stockholders.  Stockholder approval was obtained on April 17, 2026, which was the date that these options vested and became exercisable.  The remaining 50% vest in equal monthly increments over 24 months beginning May 17, 2026."}],"balance_after":60000,"derivative":{"exercise_price":2.33,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001214659-26-009587","document":"marketforms-73671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465926009587/marketforms-73671.xml","form_type":"5"}},{"id":2307838,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T21:00:20.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":20000,"price":1.2101,"value":24202.0,"ownership":{"direct":true},"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001214659-22-004803","document":"marketforms-55961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465922004803/marketforms-55961.xml","form_type":"4"}},{"id":2333099,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2022-03-15T23:12:26.000Z","date":"2022-03-15","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"2,778 and 47,222 restricted shares previously vested on September 13, 2021 and October 13, 2021, respectively, with the final 50,000 shares of restricted stock vesting on March 15, 2022."}],"balance_after":0,"derivative":{"expiration_date":"2022-03-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001214659-22-003987","document":"marketforms-55804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465922003987/marketforms-55804.xml","form_type":"4"}},{"id":2333098,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-15T23:12:26.000Z","date":"2022-03-15","kind":"exercise","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the vesting of restricted stock."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001214659-22-003987","document":"marketforms-55804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465922003987/marketforms-55804.xml","form_type":"4"}},{"id":2469686,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T22:00:17.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":20000,"price":2.8543,"value":57086.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $2.8543. The range of sale prices on the transaction date was $2.85 to $2.87 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price"}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001214659-21-013288","document":"marketforms-54671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465921013288/marketforms-54671.xml","form_type":"4"}},{"id":2540435,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2021-10-18T21:00:39.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":47222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022.  2,778 shares previously vested on September 13, 2021."}],"balance_after":50000,"derivative":{"expiration_date":"2022-03-15","underlying":"Common Stock","underlying_shares":47222},"source":{"system":"sec-edgar","filing":"0001214659-21-010559","document":"marketforms-54021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465921010559/marketforms-54021.xml","form_type":"4"}},{"id":2540434,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-18T21:00:39.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":47222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the vesting of restricted stock."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001214659-21-010559","document":"marketforms-54021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465921010559/marketforms-54021.xml","form_type":"4"}},{"id":2569149,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2021-09-15T21:00:47.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock grant vests in 36 equal monthly installments commencing on September 13, 2021."}],"balance_after":97222,"derivative":{"expiration_date":"2024-09-13","underlying":"Common Stock","underlying_shares":2778},"source":{"system":"sec-edgar","filing":"0001214659-21-009539","document":"marketforms-53817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465921009539/marketforms-53817.xml","form_type":"4"}},{"id":2569148,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T21:00:47.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":2778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the vesting of restricted stock."}],"balance_after":2778,"source":{"system":"sec-edgar","filing":"0001214659-21-009539","document":"marketforms-53817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465921009539/marketforms-53817.xml","form_type":"4"}},{"id":2631876,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-07-16T21:01:31.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options (the \"Options\") vest in 36 equal monthly installments commencing on September 13, 2021 and are exercisable upon vesting."}],"balance_after":300000,"derivative":{"exercise_price":2.5,"expiration_date":"2026-09-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001214659-21-007598","document":"marketforms-53418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465921007598/marketforms-53418.xml","form_type":"4"}},{"id":2631875,"issuer":{"id":8081,"kind":"organization","name":"Alzamend Neuro, Inc."},"owners":[{"id":26608,"kind":"person","name":"GUSTAFSON MARK","position":1,"cik":"0001303996","reported_name":"GUSTAFSON MARK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Grant","published_at":"2021-07-16T21:01:31.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock grant vest contemporaneously with the Options (as defined below)."}],"balance_after":100000,"derivative":{"expiration_date":"2024-09-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001214659-21-007598","document":"marketforms-53418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1303996/000121465921007598/marketforms-53418.xml","form_type":"4"}}]}